6505--Acamprosate CA EC Tablets

The Department of Veterans Affairs is seeking a supplier to provide Acamprosate CA EC Tablets for use in their Pharmaceutical Prime Vendor (PPV) program. The contract will be for a base year with four one-year option periods. The successful offeror will be required to provide the tablets at a fixed price, and the Government will evaluate offers based on price and technical acceptability. The offeror must submit a price for the base year and all four option years, and the price must include a 0.5% Cost Recovery Fee. The offeror must also provide a unique 11-digit National Drug Code (NDC) number for the product. Key considerations for this opportunity include: • The ability to provide the product at a competitive price • The ability to meet the technical requirements of the solicitation, including the provision of a unique NDC number • The ability to comply with all applicable laws and regulations, including those related to the PPV program • The ability to establish a business-to-business agreement with the PPV contractors Some of the key requirements for the product include: • The product must be FDA-approved • The product must be manufactured in accordance with current Good Manufacturing Practices (cGMP) • The product must be packaged in a unit-of-use bottle with a safety-cap capable of having the outer part of the cap deshelled and/or a convertible cap to produce a non-safety cap • The product must be bar-coded with a linear bar code that conforms to all GS1-128 (formerly EAN.UCC) or Health Industry Business Communication Council (HIBCC) Health Industry Bar Code (HIBC) supplier labeling standards